Key facts
- Notable investors include K2 & Associates Investment Management.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Vimy Pharma
- ·The full record, as it builds
Funding rounds
No funding rounds for Vimy Pharma are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Vimy Pharma
Manufacturers of pharmaceutical medicines intended to improve treatment and support healthcare systems. The company provides affordable medicines with a focus on supporting the sustainability of publicly funded healthcare systems, alignment with rigorous regulatory and safety standards, efforts to reduce reliance on foreign sources, and support for local manufacturing, enabling healthcare institutions to access affordable treatments for chronic diseases and sustaining domestic supply.
- Sector
- Healthcare
- HQ
- Toronto, Canada
- Founded
- 2024
- Website
- vimypharma.com/
- Ownership
- Privately Held (backing)
Vimy Pharma doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Vimy Pharma shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Vimy Pharma in its N-PORT filings yet. We sweep new filings monthly.